Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.16 $39,634 - $78,659
15,244 New
15,244 $103,000
Q2 2022

Aug 15, 2022

SELL
$2.46 - $5.2 $42,936 - $90,760
-17,454 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.16 - $9.08 $28,620 - $62,470
6,880 Added 65.07%
17,454 $83,000
Q4 2021

Feb 14, 2022

BUY
$7.65 - $11.38 $80,891 - $120,332
10,574 New
10,574 $90,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.